dual gip/glp-1 receptor agonist GLP-1/GIP agonists mechanism of action The mechanisms of dual incretin
Description
In another, 6.8% discontinued the medication entirely due to these effects

Efficacy and safety of co-administered once-weekly cagrilintide 24 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial

Obes Med

Available: [16] A

[DOI] [PMC free article] [PubMed] [Google Scholar] 652.Asmar M., Simonsen L., Arngrim N., Holst J.J., Dela F., Bulow J

Expert Opinion on Drug Metabolism & Toxicology